Aurora Kinase(极光激酶)
Aurora kinases are a family of serine-threonine kinases of three highly homologous members, including aurora A kinase, aurora B kinase and aurora C kinase, which are responsible for chromosome assembly and segregation during mitosis. Aurora kinases are characterized by two domains: a regulatory domain in the NH2 terminus and a catalytic domain in the COOH terminus, in which an A-Box and a D-Box found correspondingly in each domain are responsible for protein degradation. Aurora A kinase plays an important role in centrosome function and duplication, mitotic entry and bipolar spindle assembly; while Aurora B kinase is the catalytic component of the chromosomal passenger complex regulating the accurate segregation of the chromatids at mitosis, histone modification and cytokinesis. Aurora C kinase is less studied and expressed restrictedly in the testes.
Products for Aurora Kinase
- Cat.No. 产品名称 Information
- GC70030 Tinengotinib Tinengotinib 是一种或多种蛋白激酶的调节剂,例如 Aurora 激酶和 VEGFR 激酶。Tinengotinib 具有研究这些激酶异常介导的疾病的潜力,尤其是癌症相关疾病 (摘自专利 WO2018108079A1)。
- GC69068 ENMD-2076 Tartrate ENMD-2076 Tartrate 是多靶点激酶抑制剂,抑制 Aurora A,Flt3,KDR/VEGFR2,Flt4/VEGFR3,FGFR1,FGFR2,Src,PDGFRα 的IC50 值分别为1.86,14,58.2,15.9,92.7,70.8,20.2 and 56.4 nM。
- GC25940 SNS-314 SNS-314 is a potent and selective inhibitor of Aurora A, Aurora B and Aurora C with IC50 of 9 nM, 31 nM, and 3 nM, respectively. It is less potent to Trk A/B, Flt4, Fms, Axl, c-Raf and DDR2. Phase 1.
- GC68147 dAURK-4 hydrochloride dAURK-4 hydrochloride 是 Alisertib 的一种衍生物,是一种有效的选择性 AURKA (Aurora A) 降解剂。dAURK-4 hydrochloride 具有抗癌作用。
- GC67899 Aurora kinase inhibitor-8 Aurora kinase inhibitor-8 是一种高选择性 Aurora 激酶的抑制剂。
- GC62482 TAS-119 TAS-119 是一种有效的,选择性的,具有口服活性的 Aurora A 抑制剂,IC50 为 1.0 nM。TAS-119 对 Aurora A 的选择性高于其他蛋白激酶,包括 Aurora B (IC50 为 95 nM)。TAS-119 具有有效的抗肿瘤活性。
- GC62433 AKI603 AKI-603 is an inhibitor of Aurora kinase A (AurA), which is developed to overcome resistance mediated by BCR-ABL-T315I mutation.
- GC62189 CD532 hydrochloride An inhibitor of Aurora A kinase activity and the Aurora A-N-Myc protein-protein interaction
-
GC62145
Chiauranib
CS2164
Chiauranib (CS2164) selectively inhibits multiple kinase targets aurora B kinase (AURKB), colony-stimulating factor 1 receptor (CSF1R), and vascular endothelial growth factor receptor (VEGFR)/platelet-derived growth factor receptor (PDGFR)/c-Kit , thereby inhibiting the rapid proliferation of tumor cells, enhancing the antitumor immunity, and inhibiting tumor angiogenesis, to achieve the anti-tumor efficacy. - GC50050 Hesperadin hydrochloride A multi-kinase inhibitor
-
GC38519
Ilorasertib hydrochloride
ABT-348 hydrochloride
A multi-kinase inhibitor - GC37606 SCH-1473759 hydrochloride SCH-1473759 hydrochloride是多靶点的的极光激酶 (aurora) 抑制剂,对极光激酶A和B的IC50 值分别为4 和13 nM。
-
GC35651
Cenisertib
AS-703569; R-763
Cenisertib (AS-703569) 是一种多激酶抑制剂,可抑制 Aurora-kinase-A/B,ABL1,AKT,STAT5, FLT3 的活性。 Cenisertib 通过抑制肿瘤肥大细胞 (MC) 中几种不同分子靶标的活性抑制其生长。 Cenisertib 抑制异种移植模型中胰腺癌,乳腺癌,结肠癌,卵巢癌和肺癌以及白血病的肿瘤生长。 - GC35216 AAPK-25 AAPK-25 是一种有效选择性的 Aurora/PLK 激酶双重抑制剂,具有抗肿瘤活性。AAPK-25 可引起有丝分裂延迟并阻滞前中期细胞,通过生物标志物组蛋白 H3Ser10 磷酸化反应,随后细胞凋亡激增。AAPK-25 靶向 Aurora-A, -B, -C 的 Kd 值为 23 nM-289 nM,靶向 PLK-1, -2, -3 的 Kd 值为 55-456 nM。
-
GC40667
Aurora Kinase Inhibitor II
4-(4-Benzamidoanilino)-6,7-dimethoxyquinazoline
Blocks Aurora A kinase activity - GC34692 NU6140 A Cdk2 inhibitor
-
GC34159
Ilorasertib (ABT-348)
ABT-348
A multi-kinase inhibitor - GC33379 Aurora B inhibitor 1 AuroraBinhibitor1是一种AuroraB(Aurora-1)抑制剂,Ki值<0.010uM。详细信息请参考专利文献WO2007059299A1中的化合物1-3。
-
GC33057
LY3295668 (AK-01)
AK-01
LY3295668 (AK-01) is a potent, orally active and specific inhibitor of Aurora A kinase with Ki of 0.8 nM and 1038 nM for AURKA and AURKB, respectively. - GC19092 CCT241736 A dual inhibitor of Aurora kinases and FLT3
- GC17828 BI-847325 A selective dual MEK/Aurora kinase inhibitor
- GC10442 MK-8745 An Aurora A kinase inhibitor
- GC17455 TAK-632 A selective pan-Raf inhibitor
- GC16378 TC-A 2317 hydrochloride TC-A 2317 hydrochloride 是一种具有口服活性的 Aurora A 激酶抑制剂 (Ki=1.2 nM)。 TC-A 2317 hydrochloride 对 Aurora B 激酶 (Ki=101 nM) 和其他 60 种激酶具有出色的选择性、良好的细胞渗透性和良好的 PK 曲线。抗肿瘤活性。
-
GC17284
Anacardic acid
漆树酸; Hydroginkgolic acid; Ginkgolic Acid C15
A histone acetyltransferase inhibitor
-
GC13102
XL228
N4-(5-环丙基-1H-吡唑-3-基)-N2-[[3-异丙基-5-异恶唑基]甲基]-6-(4-甲基-1-哌嗪基)-2,4-嘧啶二胺,XL-228;XL 228
A tyrosine kinase inhibitor -
GC16614
SCH-1473759
SCH1473759;SCH 1473759
SCH-1473759 是一种极光抑制剂,对极光 A 和 B 的 IC50 分别为 4 和 13 nM。 -
GC14651
Reversine
逆转素
A purine derivative -
GC14709
AZD1152
5-[[7-[3-[乙基[2-(磷酰氧基)乙基]氨基]丙氧基]-4-喹唑啉基]氨基]-N-(3-氟苯基)-1H-吡唑-3-乙酰胺,AZD-1152;AZD 1152
AZD1152 (AZD1152) 是 AZD1152-hQPA 的前药,是一种高选择性的 Aurora B 抑制剂,在无细胞试验中 IC50 为 0.37 nM。 AZD1152 (AZD1152) 在癌细胞中诱导生长停滞和凋亡。 -
GC18074
PF-03814735
N-[2-[(1S,4R)-6-[[4-(环丁基氨基)-5-(三氟甲基)-2-嘧啶基]氨基]-1,2,3,4-四氢萘-1,4-亚氨-9-基]-2-氧代乙基]乙酰胺
PF-03814735 是一种有效的、具有口服生物利用度的 Aurora1 和 Aurora2 激酶的可逆抑制剂,IC50 值分别为 0.8nM 和 5nM 。 -
GC10008
GSK1070916
GSK-1070916A
A potent inhibitor of Aurora B and C kinases - GC13332 Aurora A Inhibitor I A potent and selective inhibitor of Aurora A kinase
- GC15106 CYC116 A potent Aurora kinase inhibitor
-
GC11085
TAK-901
5-[3-(乙基磺酰基)苯基]-3,8-二甲基-N-(1-甲基-4-哌啶基)-9H-吡啶并[2,3-B]吲哚-7-甲酰胺
A non-selective inhibitor of Aurora kinases -
GC14592
KW 2449
[4-[2-(1H-吲唑-3-基)乙烯基]苯基]-1-哌嗪基甲酮
A multi-kinase inhibitor -
GC10479
PHA-680632
Pha 680632
An Aurora kinase inhibitor -
GC13837
SNS-314 Mesylate
N-(3-氯苯基)-N'-[5-[2-(噻吩并3,2-D]嘧啶-4-基氨基)乙基]-2-噻唑基]脲甲磺酸盐(1:1)
A pan-Aurora kinase inhibitor -
GC17162
MK-5108 (VX-689)
VX-689
A potent inhibitor of Aurora kinases - GC13198 AMG-900 A selective pan-Aurora kinase inhibitor
- GC17196 Hesperadin A multi-kinase inhibitor
- GC10638 AT9283 A broad spectrum kinase inhibitor
-
GC15217
Danusertib (PHA-739358)
达鲁舍替,5-Amido-pyrrolopyrazole 9d
A pan-Aurora kinase and Abl inhibitor -
GC12612
JNJ-7706621
JNJ7706621, JNJ 7706621
A dual inhibitor of CDKs and Aurora kinases -
GC12208
MLN8054
4-[[9-氯-7-(2,6-二氟苯基)-5H-嘧啶并[5,4-D][2]苯并氮杂卓-2-基]氨基]苯甲酸
An inhibitor of Aurora A kinase -
GC14566
CCT137690
甲磺酸阿贝西尼
An inhibitor of Aurora kinases and FLT3 -
GC11310
CCT129202
2-[4-[6-氯-2-(4-二甲基氨基苯基)-3H-咪唑并[4,5-B]吡啶-7-基]哌嗪-1-基]-N-(噻唑-2-基)乙酰胺,CCT-129202, CCT 129202
An Aurora kinase inhibitor -
GC16519
ENMD-2076
6-(4-甲基-1-哌嗪基)-N-(5-甲基-1H-吡唑-3-基)-2-[(1E)-2-苯乙烯基]-4-嘧啶胺
A multi-kinase inhibitor - GC12145 ENMD-2076 L-(+)-Tartaric acid ENMD-2076 L-(+)-Tartaric acid 是一种多靶点激酶抑制剂,对 Aurora A、Flt3、KDR/VEGFR2、Flt4/VEGFR3、FGFR1 的 IC50 为 1.86、14、58.2、15.9、92.7、70.8、56.4 nM , FGFR2, Src, PDGFRα, 分别。
- GC14409 ZM 447439 Selective inhibitor of Aurora B kinase
-
GC14955
Barasertib (AZD1152-HQPA)
5-[[7-[3-[乙基(2-羟基乙基)氨基]丙氧基]-4-喹唑啉]氨基]-N-(3-氟苯基)-1H-吡唑-3-乙酰胺,AZD1152-HQPA,AZD-1152HQPA, AZD1152 HPQA,INH 34
A selective Aurora kinase B inhibitor